These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31606301)

  • 1. Editorial overview: The gut microbiome: Its role in disorders of the GI tract and metabolic homeostasis.
    Evrensel A; Ceylan ME
    Curr Opin Pharmacol; 2019 Dec; 49():iii-v. PubMed ID: 31606301
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting gut flora to treat and prevent disease.
    Schneiderhan J; Master-Hunter T; Locke A
    J Fam Pract; 2016 Jan; 65(1):34-8. PubMed ID: 26845162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut Microbiome and Probiotics.
    Fatima A; Sylvester FA
    Adolesc Med State Art Rev; 2016; 27(1):140-54. PubMed ID: 27363238
    [No Abstract]   [Full Text] [Related]  

  • 4. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation.
    Jayasinghe TN; Chiavaroli V; Holland DJ; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2016; 6():15. PubMed ID: 26925392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and health.
    Kc D; Sumner R; Lippmann S
    Postgrad Med; 2020 Apr; 132(3):274. PubMed ID: 31566046
    [No Abstract]   [Full Text] [Related]  

  • 6. Acupuncture influences multiple diseases by regulating gut microbiota.
    Xu H; Luo Y; Li Q; Zhu H
    Front Cell Infect Microbiol; 2024; 14():1371543. PubMed ID: 39040602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.
    Borody T; Fischer M; Mitchell S; Campbell J
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1379-91. PubMed ID: 26414076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on the effect of gut microbiota on metabolic diseases.
    Shi Q; Dai L; Zhao Q; Zhang X
    Arch Microbiol; 2022 Feb; 204(3):192. PubMed ID: 35195774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Journal of Nutritional Biochemistry Special Issue: nutritional modulation of the gut microbiome in gastrointestinal and metabolic disease.
    Pierre JF; Leone V; Martinez-Guryn K
    J Nutr Biochem; 2019 Apr; 66():110-112. PubMed ID: 30784995
    [No Abstract]   [Full Text] [Related]  

  • 11. Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration.
    Parker EA; Roy T; D'Adamo CR; Wieland LS
    Nutrition; 2018 Jan; 45():125-134.e11. PubMed ID: 28870406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Link Between Gut Microbiota and Cerebral Functions: An Update on the Pathogenesis and Treatment of Functional Gastrointestinal Disorders].
    Kurokawa S
    Brain Nerve; 2021 Aug; 73(8):857-862. PubMed ID: 34376591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the gastrointestinal microbiota in small animal health and disease.
    Redfern A; Suchodolski J; Jergens A
    Vet Rec; 2017 Oct; 181(14):370. PubMed ID: 28916525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Schmulson M; Bashashati M
    Curr Opin Pharmacol; 2018 Dec; 43():72-80. PubMed ID: 30218939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
    Schiattarella GG; Sannino A; Esposito G; Perrino C
    Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases.
    Han Z; Min Y; Pang K; Wu D
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 20. Fecal microbiota transplantation: past, present and future perspectives.
    Bibbò S; Ianiro G; Gasbarrini A; Cammarota G
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):420-430. PubMed ID: 28927251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.